盤龍藥業(002864.SZ):獲得設立陝西省醫療機構集中配製中心備案
格隆匯1月20日丨盤龍藥業(002864.SZ)公佈,公司近日收到陝西省藥品監督管理局《陝西省藥品監督管理局關於同意陝西盤龍藥業集團股份有限公司設立陝西省醫療機構集中配製中心的備案批覆》(陝藥監函[2021]29號)文件,同意公司提出的設立陝西省醫療機構集中配製中心的備案申請。
經陝西省藥品監督管理局經資料審核和現場檢查,公司現持有的《藥品生產許可證》所載明生產範圍及現場核實的生產能力基本滿足醫療機構院內製劑相關劑型及配置需求,符合《醫院製劑配製質量管理規範》和《陝西省醫療機構製劑集中配置中心評定指導原則》(試行)的相關要求,經研究,同意公司提出的陝西省醫療機構製劑集中配置中心備案申請。公司將根據陝西省藥品監督管理局文件要求,持續加強內部質量管理,嚴格執行相關法律法規,確保所配置的醫療機構製劑產品質量安全。
此次公司獲得《陝西省藥品監督管理局關於同意陝西盤龍藥業集團股份有限公司設立陝西省醫療機構集中配製中心的備案批覆》,有利於拓展在陝西省醫療機構集中配製領域的產品生產和配送佈局,對公司未來發展有着積極的推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.